Investigational drug · Phase 3
Libevitug
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Chronic Hepatitis D Infection.
Phase 3Last checked: Nov 19, 2026Latest source record: Aug 24, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "Libevitug"
First trial start
2026
Apr 22, 2026
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "Libevitug", any sponsor or status.
Conditions studied
As listed on its trial records.
- Chronic Hepatitis D Infection
Approved drugs for the same conditions: Infectious disease and vaccines
Largest trials
Live from ClinicalTrials.gov: studies naming "Libevitug" as an intervention, largest first.
- A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear Study)Pivotal-lookingRecruiting
Huahui HealthIndustry
NCT07499544 · 160 participants (planned) · Start Apr 22, 2026 · Primary completion Sep 12, 2028
Drug: Libevitug 20 mg/kg; Libevitug 10 mg/kg · For: Chronic Hepatitis D Infection
Sites: Garden Grove, California; Changchun, China; Kashgar, China · 7 sites in all
Newest research
PubMed records naming it or its code names, newest first.
- Safety and efficacy of libevitug in patients with chronic hepatitis B and D virus coinfection: A single-center, open-label, phase IIa trial in China.
Wang X, Chi X, Zhang Y, et al. · Hepatol Commun 2026
Also in development for Chronic Hepatitis D Infection
- BrelovitugBJT-778, BTGPhase 34 trials
Mirum Pharmaceuticals, Inc. · Chronic Hepatitis D Infection, Chronic Hepatitis D
- ABI-6250Phase 21 trial
Assembly Biosciences · Chronic Hepatitis D Infection
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.